Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Net Margin (2016 - 2026)

Cryo Cell International's Net Margin history spans 17 years, with the latest figure at 0.61% for Q1 2026.

  • Quarterly results put Net Margin at 0.61% for Q1 2026, down 294.0% from a year ago — trailing twelve months through Feb 2026 was 8.52% (down 892.0% YoY), and the annual figure for FY2025 was 7.7%, down 895.0%.
  • Net Margin for Q1 2026 was 0.61% at Cryo Cell International, up from 48.67% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 13.04% in Q3 2024 to a low of 142.06% in Q4 2023.
  • The 5-year median for Net Margin is 7.08% (2024), against an average of 6.44%.
  • The sharpest move saw Net Margin tumbled -15286bps in 2023, then surged 11886bps in 2024.
  • Year by year, Net Margin stood at 10.79% in 2022, then plummeted by -1417bps to 142.06% in 2023, then surged by 84bps to 23.2% in 2024, then plummeted by -110bps to 48.67% in 2025, then surged by 101bps to 0.61% in 2026.
  • According to Business Quant data, Net Margin over the past three periods came in at 0.61%, 48.67%, and 9.58% for Q1 2026, Q4 2025, and Q3 2025 respectively.